Human immunodeficiency virus (HIV)-negative plasmablastic lymphoma: A single institutional experience and literature review

2011 ◽  
Vol 35 (12) ◽  
pp. 1571-1577 ◽  
Author(s):  
Jane Jijun Liu ◽  
Ling Zhang ◽  
Ernesto Ayala ◽  
Teresa Field ◽  
Jose L. Ochoa-Bayona ◽  
...  
2021 ◽  
Vol 84 (4) ◽  
pp. 659-661
Author(s):  
L Bricman ◽  
P Yengue ◽  
C Miscu ◽  
S Junius ◽  
F Waignein ◽  
...  

Plasmablastic lymphoma (PBL) represents a rare and aggressive subtype of diffuse large B cells lymphoma (DLBCL) most associated with the human immunodeficiency virus (HIV). Prognosis remains poor despite various treatment approaches. We describe an evolution at six months of HIV negative PBL and Ebstein Barr virus (EBV) positive PBL with chemotherapy. Role of radiotherapy is still unclear.


2013 ◽  
Vol 2013 ◽  
pp. 1-6 ◽  
Author(s):  
Ing Soo Tiong ◽  
Magreet Strauss ◽  
Michael B. Y. Lau ◽  
Shingirai Chiruka

We report a case of Epstein-Barr-virus-(EBV-) positive primary cutaneous plasmablastic lymphoma in a human-immunodeficiency-virus-(HIV-) negative, immunocompetent 62-year-old female patient. We postulate that her lymphoma development is due to the longstanding use of pyrimethamine for essential thrombocythemia. This has never been described in the literature.


2017 ◽  
Vol 3 (2) ◽  
pp. 20160124
Author(s):  
Jae Pil Hwang ◽  
Soo-Ho Jeong ◽  
Hee Kyung Kim ◽  
Jung Mi Park

2019 ◽  
Vol 2019 ◽  
pp. 1-4
Author(s):  
Alaina J. Kessler ◽  
Bridget K. Marcellino ◽  
Scot A. Niglio ◽  
Bruce E. Petersen ◽  
Adriana K. Malone

Plasmablastic lymphoma (PBL) and plasmablastic plasma cell myeloma (PCM) have many overlapping characteristics. Clinical correlation can help make the distinction between the two entities. Human immunodeficiency virus- (HIV-) negative PBL is a rare disease, making the diagnosis more challenging. While there is no standard of care for PBL, current recommendations include dose-adjusted EPOCH (etoposide, vincristine, doxorubicin, cyclophosphamide, and prednisone), with or without bortezomib. We report an aggressive case of HIV-negative plasmablastic lymphoma and discuss the challenge in establishing a diagnosis. We review the literature regarding this disease and current recommendations for treatment.


2013 ◽  
Vol 34 (2) ◽  
pp. 96 ◽  
Author(s):  
Atul Sharma ◽  
T. V. S. V. G. K. Tilak ◽  
Rakesh Lodha ◽  
MC Sharma ◽  
Deepak Dabkara

2021 ◽  
Vol 9 ◽  
pp. 232470962110146
Author(s):  
Roopam Jariwal ◽  
Nadia Raza ◽  
Janpreet Bhandohal ◽  
Everardo Cobos

Plasmablastic lymphoma (PBL) is a subtype of non-Hodgkin’s lymphoma that manifests in patients with the diagnosis of human immunodeficiency virus (HIV), more prominently in the head, neck, and oral mucosal region. The diagnosis of this rare lymphoma serves as a concomitant diagnosis of acquired immunodeficiency syndrome. The case is of a 33-year-old previously healthy male, with an unknown diagnosis of HIV with a painful right mandibular mass. He was subsequently diagnosed with PBL and HIV. This case of PBL illustrates the importance of linking a rare and potentially life-threatening diagnosis as a possible first manifestation of HIV.


Author(s):  
Alvaro Quincho-Lopez ◽  
Noah Kojima ◽  
John M. Nesemann ◽  
Rogger Verona-Rubio ◽  
Dina Carayhua-Perez

AbstractCryptococcosis is a fungal infection that is rarely reported in patients without human immunodeficiency virus (HIV) infection, especially when the central nervous system (CNS) or pulmonary system is not involved. We report a case of isolated colonic cryptococcosis without disseminated disease in a 64-year-old immunocompetent woman without HIV infection who presented with chronic diarrhea and no episodes of fever or weight loss. The diagnosis was based on histopathology examination. Furthermore, we performed a literature review showing that few reports have been published so far and in the case of colonic cryptococcal infection, the prognosis is favorable among HIV-uninfected patients.


Sign in / Sign up

Export Citation Format

Share Document